Rathbones Group PLC Danaher Corp Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Danaher Corp stock. As of the latest transaction made, Rathbones Group PLC holds 311,807 shares of DHR stock, worth $71.6 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

311,807

Previous 289,997 7.52%

Holding current value

$71.6 Million

Previous $72.5 Million 19.63%

% of portfolio

0.46%

Previous 0.41%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$239.25 - $280.76 $5.22 Million - $6.12 Million	21,810 Added 7.52%	311,807 $86.7 Million
Q2 2024 Aug 09, 2024	BUY	$235.51 - $267.98 $14.7 Million - $16.8 Million	62,599 Added 27.53%	289,997 $72.5 Million
Q1 2024 May 14, 2024	BUY	$224.58 - $256.19 $798,606 - $911,011	3,556 Added 1.59%	227,398 $56.8 Million
Q4 2023 Feb 13, 2024	SELL	$185.1 - $233.13 $989,359 - $1.25 Million	-5,345 Reduced 2.33%	223,842 $51.8 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $53.2 Million - $60.6 Million	228,227 Added 23773.65%	229,187 $56.9 Million
Q2 2023 Aug 04, 2023	BUY	$224.99 - $256.14 $33,973 - $38,677	151 Added 18.67%	960 $230,000
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $195,308 - $228,372	809 New	809 $214,000
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $240,666 - $304,154	-1,015 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$257.27 - $315.76 $90,044 - $110,516	350 Added 52.63%	1,015 $298,000
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $194,233 - $218,791	665 New	665 $219,000
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $289,049 - $334,669	-1,361 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $289,212 - $334,071	1,361 New	1,361 $302,000

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $167B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Danaher Corp Transaction History